Results 31 to 40 of about 95,231 (351)

Mutations and amplification of oncogenes in endometrial cancer [PDF]

, 1999
Alterations in oncogenes are critical steps in the development of endometrial cancer. To investigate the potential clinical relevance of the amplification of the oncogenes c-erbB2, c-myc, and int-2 and the mutation of K-ras in endometrial cancer, 112 ...
An, Han-Xiang, Beckmann, Matthias W., Bender, Hans G., Cho, Yong-Jig, Hantschmann, Peer, Niederacher, Dieter   +5 more
core   +1 more source

WISDOM: history and early demise - was it inevitable?

, 2007
In 1989, the UK Medical Research Council (MRC) agreed that, if feasible, a randomized controlled trial to assess the long-term risks and benefits of hormone replacement therapy (HRT) was a priority.
Darbyshire, J, Meade, T, Vickers, M
core   +1 more source

Decreased risk of breast cancer associated with oral bisphosphonate therapy [PDF]

, 2012
Preclinical studies and adjuvant trials using bisphosphonates have found them to have an antitumor effect. Although major advances have been made in chemoprevention strategies with selective estrogen receptor modulators and aromatase inhibitors, their ...
Brufsky, A, Mathew, A
core   +2 more sources

Frequency of the Causes of Postmenopausal Bleeding, Results of a Tertiary Referral Center in Turkey

Gynecology Obstetrics & Reproductive Medicine, 2021
OBJECTIVE: In this study, we aimed to determine the frequency of etiologic factors that causes postmenopausal bleeding. STUDY DESIGN: For the purpose, a total number of 200 women with postmenopausal bleeding were included in the study.
Umit Yasemin Sert, Ismail Guler, Tuncay Nas   +2 more
doaj   +1 more source

Study protocol to investigate the effect of a lifestyle intervention on body weight, psychological health status and risk factors associated with disease recurrence in women recovering from breast cancer treatment [PDF]

, 2006
Background Breast cancer survivors often encounter physiological and psychological problems related to their diagnosis and treatment that can influence long-term prognosis.
A Campbell, A McTiernan, A McTiernan, A Silvestri, A Visser, AB Kornblith, AC Utter, AH Wu, AJ Daley, Amanda Daley, AN Dentino, AS Fairey, AT Beck, B Dugue, B Rockhill, B Zumoff, BL Andersen, BL Gruber, BL Stauffer, BM Pinto, BS McEwen, C Peters, C Peters, C Wiltschke, CB Ebbeling, CL Caldwell, CM Bryla, CM Friedenreich, D Geffken, D Nerozzi, DC McMillan, DC Nieman, DC Nieman, DC Nieman, DC Nieman, DC Nieman, DC Nieman, DF Cella, DG Cruess, DH Bovbjerg, DM Golden-Kreutz, DV Schapira, DW Kissane, E Maunsell, EA Bermudez, G Borg, G van der Pompe, G van der Pompe, GG Kolden, H Davis, H Kervinen, HC Abercrombie, Helen Crank, Hilary Powers, HV Thomas, J Gallagher, J Kaukua, J Verloop, JA Cauley, JE Bower, JE Epping-Jordan, JF Sallis, JK Camoriano, JK Smith, JO Prochaska, John M Saxton, JR Calabrese, JS Goodwin, KL Jen, KM Rexrode, KS Courneya, KS Madden, L Bernstein, L Chang, M Maes, M Maes, M Maes, M Mezzetti, MD Gammon, MD Holmes, MD Holmes, ME Nelson, MK Baldwin, N Banu, Nanette Mutrie, Nicola Woodroofe, PJ Goodwin, RJ Benschop, Robert Coleman, RT Chlebowski, S Cohen, S Levy, S Yamasaki, SE Hankinson, SE Sephton, SI Mannering, SJ Schleifer, SJH Biddle, SK Lutgendorf, SM Levy, T Moradi, T Treasure, TA Wadden, TP Erlinger, U Ehlert, Vanessa Siddall, Y Touitou, Y Touitou, Z Djuric, Z Kronfol   +109 more
core   +4 more sources

Hormonal therapies and venous thrombosis: Considerations for prevention and management

Research and Practice in Thrombosis and Haemostasis, 2022
Background Venous thromboses are well‐established complications of hormonal therapy. Thrombosis risk is seen with both hormonal contraceptive agents and with hormone replacement therapy for menopause and gender transition.
Corinne LaVasseur, Suvi Neukam, Thomas Kartika, Bethany Samuelson Bannow, Joseph Shatzel, Thomas G. DeLoughery   +5 more
doaj   +1 more source

A qualitative comparison of how older breast cancer survivors process treatment information regarding endocrine therapy. [PDF]

, 2019
BACKGROUND:It remains unclear how information about aromatase inhibitors (AI) impacts women's decision-making about persistence with endocrine therapy.
Green, Emily, Khakshooy, Sally, Pieters, Huibrie C, Sleven, Miriam, Stanton, Annette L   +4 more
core   +4 more sources

The Potential Effects of Hormonal Therapy and Stress on the Oral Health of the Transitioning Population [PDF]

, 2020
Problem: In terms of healthcare, the transgender population is underserved. Unfortunately, these individuals often experience stress related to seeking preventative care and fear discrimination.
Cantwell, Elena G, McClure, Devon
core   +1 more source

Bazedoxifene, a selective estrogen receptor modulator, reduces cerebral aneurysm rupture in Ovariectomized rats. [PDF]

, 2017
BackgroundEstrogen deficiency is thought to be responsible for the higher frequency of aneurysmal subarachnoid hemorrhage in post- than premenopausal women.
Hashimoto, Tomoki, Kitazato, Keiko T, Korai, Masaaki, Maekawa, Hidetsugu, Miyamoto, Takeshi, Nagahiro, Shinji, Satomi, Junichiro, Tada, Yoshiteru, Yagi, Kenji   +8 more
core   +1 more source

High-Dose Estradiol-Replacement Therapy Enhances the Renal Vascular Response to Angiotensin II via an AT2-Receptor Dependent Mechanism

Advances in Pharmacological Sciences, 2015
Physiological levels of estrogen appear to enhance angiotensin type 2 receptor- (AT2R-) mediated vasodilatation. However, the effects of supraphysiological levels of estrogen, analogous to those achieved with high-dose estrogen replacement therapy in ...
Tahereh Safari, Mehdi Nematbakhsh, Roger G. Evans, Kate M. Denton   +3 more
doaj   +1 more source